Elegant Marbles and Grani Industries Limited

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ULTRACEMCO.BO has a market cap of 3.8T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ULTRACEMCO.BO trades at ₹12,934.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ULTRACEMCO.BO's P/E ratio is 50.01. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ULTRACEMCO.BO's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ULTRACEMCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ULTRACEMCO.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ULTRACEMCO.NS has a market cap of 3.8T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ULTRACEMCO.NS trades at ₹12,937.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ULTRACEMCO.NS's P/E ratio is 50.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ULTRACEMCO.NS's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ULTRACEMCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ULTRACEMCO.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GRASIM.NS has a market cap of 2T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GRASIM.NS trades at ₹2,863.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GRASIM.NS's P/E ratio is 43.24. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GRASIM.NS's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to GRASIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check GRASIM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GRASIM.BO has a market cap of 1.9T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GRASIM.BO trades at ₹2,861.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GRASIM.BO's P/E ratio is 45.10. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GRASIM.BO's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to GRASIM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check GRASIM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, AMBUJACEM.NS has a market cap of 1.3T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while AMBUJACEM.NS trades at ₹512.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas AMBUJACEM.NS's P/E ratio is 34.07. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to AMBUJACEM.NS's ROE of +0.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to AMBUJACEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check AMBUJACEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, AMBUJACEM.BO has a market cap of 1.3T. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while AMBUJACEM.BO trades at ₹512.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas AMBUJACEM.BO's P/E ratio is 34.12. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to AMBUJACEM.BO's ROE of +0.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to AMBUJACEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check AMBUJACEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SHREECEM.NS has a market cap of 969.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SHREECEM.NS trades at ₹26,745.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SHREECEM.NS's P/E ratio is 54.11. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SHREECEM.NS's ROE of +0.08%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SHREECEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SHREECEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SHREECEM.BO has a market cap of 968.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SHREECEM.BO trades at ₹26,734.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SHREECEM.BO's P/E ratio is 56.37. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SHREECEM.BO's ROE of +0.08%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SHREECEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SHREECEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JKCEMENT.BO has a market cap of 437.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JKCEMENT.BO trades at ₹5,738.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JKCEMENT.BO's P/E ratio is 42.28. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JKCEMENT.BO's ROE of +0.17%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JKCEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JKCEMENT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JKCEMENT.NS has a market cap of 437.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JKCEMENT.NS trades at ₹5,730.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JKCEMENT.NS's P/E ratio is 42.18. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JKCEMENT.NS's ROE of +0.17%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JKCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JKCEMENT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, DALBHARAT.BO has a market cap of 386.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while DALBHARAT.BO trades at ₹2,062.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas DALBHARAT.BO's P/E ratio is 32.57. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to DALBHARAT.BO's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to DALBHARAT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check DALBHARAT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, DALBHARAT.NS has a market cap of 383.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while DALBHARAT.NS trades at ₹2,061.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas DALBHARAT.NS's P/E ratio is 32.32. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to DALBHARAT.NS's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to DALBHARAT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check DALBHARAT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ACC.NS has a market cap of 304.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ACC.NS trades at ₹1,613.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ACC.NS's P/E ratio is 11.54. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ACC.NS's ROE of +0.14%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ACC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ACC.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ACC.BO has a market cap of 304.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ACC.BO trades at ₹1,613.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ACC.BO's P/E ratio is 11.54. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ACC.BO's ROE of +0.14%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ACC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ACC.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, RAMCOCEM.BO has a market cap of 272.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while RAMCOCEM.BO trades at ₹1,139.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas RAMCOCEM.BO's P/E ratio is 47.43. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to RAMCOCEM.BO's ROE of +0.08%. Regarding short-term risk, ELEMARB.BO is more volatile compared to RAMCOCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check RAMCOCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, RAMCOCEM.NS has a market cap of 272.1B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while RAMCOCEM.NS trades at ₹1,140.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas RAMCOCEM.NS's P/E ratio is 47.29. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to RAMCOCEM.NS's ROE of +0.08%. Regarding short-term risk, ELEMARB.BO is more volatile compared to RAMCOCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check RAMCOCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JSWCEMENT.BO has a market cap of 167.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JSWCEMENT.BO trades at ₹127.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JSWCEMENT.BO's P/E ratio is -15.30. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JSWCEMENT.BO's ROE of -0.26%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JSWCEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JSWCEMENT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JSWCEMENT.NS has a market cap of 167.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JSWCEMENT.NS trades at ₹127.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JSWCEMENT.NS's P/E ratio is -15.29. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JSWCEMENT.NS's ROE of -0.26%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JSWCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JSWCEMENT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, INDIACEM.BO has a market cap of 130.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while INDIACEM.BO trades at ₹424.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas INDIACEM.BO's P/E ratio is -119.69. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to INDIACEM.BO's ROE of -0.01%. Regarding short-term risk, ELEMARB.BO is more volatile compared to INDIACEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check INDIACEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, INDIACEM.NS has a market cap of 130.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while INDIACEM.NS trades at ₹425.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas INDIACEM.NS's P/E ratio is -119.67. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to INDIACEM.NS's ROE of -0.01%. Regarding short-term risk, ELEMARB.BO is more volatile compared to INDIACEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check INDIACEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NUVOCO.NS has a market cap of 118.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NUVOCO.NS trades at ₹331.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NUVOCO.NS's P/E ratio is 30.89. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NUVOCO.NS's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is more volatile compared to NUVOCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check NUVOCO.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NUVOCO.BO has a market cap of 118.5B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NUVOCO.BO trades at ₹332.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NUVOCO.BO's P/E ratio is 30.83. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NUVOCO.BO's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is more volatile compared to NUVOCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check NUVOCO.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JKLAKSHMI.BO has a market cap of 90.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JKLAKSHMI.BO trades at ₹728.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JKLAKSHMI.BO's P/E ratio is 19.58. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JKLAKSHMI.BO's ROE of +0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JKLAKSHMI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JKLAKSHMI.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, JKLAKSHMI.NS has a market cap of 90.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while JKLAKSHMI.NS trades at ₹726.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas JKLAKSHMI.NS's P/E ratio is 19.57. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to JKLAKSHMI.NS's ROE of +0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to JKLAKSHMI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check JKLAKSHMI.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, STARCEMENT.BO has a market cap of 88B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while STARCEMENT.BO trades at ₹215.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas STARCEMENT.BO's P/E ratio is 23.88. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to STARCEMENT.BO's ROE of +0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to STARCEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check STARCEMENT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, STARCEMENT.NS has a market cap of 87.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while STARCEMENT.NS trades at ₹216.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas STARCEMENT.NS's P/E ratio is 23.83. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to STARCEMENT.NS's ROE of +0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to STARCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check STARCEMENT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BIRLACORPN.BO has a market cap of 77B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BIRLACORPN.BO trades at ₹985.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BIRLACORPN.BO's P/E ratio is 14.84. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BIRLACORPN.BO's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to BIRLACORPN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check BIRLACORPN.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BIRLACORPN.NS has a market cap of 77B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BIRLACORPN.NS trades at ₹988.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BIRLACORPN.NS's P/E ratio is 14.83. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BIRLACORPN.NS's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to BIRLACORPN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check BIRLACORPN.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, PRSMJOHNSN.NS has a market cap of 63.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while PRSMJOHNSN.NS trades at ₹126.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas PRSMJOHNSN.NS's P/E ratio is 32.36. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to PRSMJOHNSN.NS's ROE of +0.12%. Regarding short-term risk, ELEMARB.BO is more volatile compared to PRSMJOHNSN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check PRSMJOHNSN.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, PRSMJOHNSN.BO has a market cap of 63.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while PRSMJOHNSN.BO trades at ₹126.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas PRSMJOHNSN.BO's P/E ratio is 32.33. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to PRSMJOHNSN.BO's ROE of +0.12%. Regarding short-term risk, ELEMARB.BO is more volatile compared to PRSMJOHNSN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check PRSMJOHNSN.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, HEIDELBERG.BO has a market cap of 37.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while HEIDELBERG.BO trades at ₹162.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas HEIDELBERG.BO's P/E ratio is 28.92. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to HEIDELBERG.BO's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to HEIDELBERG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check HEIDELBERG.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, HEIDELBERG.NS has a market cap of 37.1B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while HEIDELBERG.NS trades at ₹162.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas HEIDELBERG.NS's P/E ratio is 26.69. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to HEIDELBERG.NS's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to HEIDELBERG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check HEIDELBERG.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ORIENTCEM.NS has a market cap of 32.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ORIENTCEM.NS trades at ₹157.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ORIENTCEM.NS's P/E ratio is 10.01. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ORIENTCEM.NS's ROE of +0.17%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ORIENTCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ORIENTCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ORIENTCEM.BO has a market cap of 32.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ORIENTCEM.BO trades at ₹157.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ORIENTCEM.BO's P/E ratio is 9.97. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ORIENTCEM.BO's ROE of +0.17%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ORIENTCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ORIENTCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, MANGLMCEM.BO has a market cap of 25.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while MANGLMCEM.BO trades at ₹911.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas MANGLMCEM.BO's P/E ratio is 32.88. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to MANGLMCEM.BO's ROE of +0.09%. Regarding short-term risk, ELEMARB.BO is more volatile compared to MANGLMCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check MANGLMCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, MANGLMCEM.NS has a market cap of 25.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while MANGLMCEM.NS trades at ₹913.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas MANGLMCEM.NS's P/E ratio is 31.47. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to MANGLMCEM.NS's ROE of +0.09%. Regarding short-term risk, ELEMARB.BO is more volatile compared to MANGLMCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check MANGLMCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SAGCEM.NS has a market cap of 25.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SAGCEM.NS trades at ₹192.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SAGCEM.NS's P/E ratio is -15.13. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SAGCEM.NS's ROE of -0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SAGCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SAGCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SAGCEM.BO has a market cap of 25.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SAGCEM.BO trades at ₹192.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SAGCEM.BO's P/E ratio is -15.09. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SAGCEM.BO's ROE of -0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SAGCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SAGCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, EPACK.NS has a market cap of 24B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while EPACK.NS trades at ₹251.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas EPACK.NS's P/E ratio is 58.15. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to EPACK.NS's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is more volatile compared to EPACK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check EPACK.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KCP.BO has a market cap of 20.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KCP.BO trades at ₹159.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KCP.BO's P/E ratio is 13.94. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KCP.BO's ROE of +0.09%. Regarding short-term risk, ELEMARB.BO is more volatile compared to KCP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check KCP.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KCP.NS has a market cap of 20.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KCP.NS trades at ₹159.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KCP.NS's P/E ratio is 13.92. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KCP.NS's ROE of +0.09%. Regarding short-term risk, ELEMARB.BO is more volatile compared to KCP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check KCP.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, UDAICEMENT.NS has a market cap of 20.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while UDAICEMENT.NS trades at ₹36.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas UDAICEMENT.NS's P/E ratio is 201.28. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to UDAICEMENT.NS's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to UDAICEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check UDAICEMENT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, UDAICEMENT.BO has a market cap of 20.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while UDAICEMENT.BO trades at ₹36.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas UDAICEMENT.BO's P/E ratio is 201.06. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to UDAICEMENT.BO's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to UDAICEMENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check UDAICEMENT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SANGHIIND.BO has a market cap of 15.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SANGHIIND.BO trades at ₹61.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SANGHIIND.BO's P/E ratio is -3.74. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SANGHIIND.BO's ROE of -0.69%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SANGHIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SANGHIIND.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SANGHIIND.NS has a market cap of 15.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SANGHIIND.NS trades at ₹61.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SANGHIIND.NS's P/E ratio is -3.72. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SANGHIIND.NS's ROE of -0.69%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SANGHIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SANGHIIND.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, IFGLEXPOR.NS has a market cap of 12.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while IFGLEXPOR.NS trades at ₹170.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas IFGLEXPOR.NS's P/E ratio is 43.06. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to IFGLEXPOR.NS's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to IFGLEXPOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check IFGLEXPOR.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, IFGLEXPOR.BO has a market cap of 12.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while IFGLEXPOR.BO trades at ₹169.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas IFGLEXPOR.BO's P/E ratio is 42.73. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to IFGLEXPOR.BO's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is more volatile compared to IFGLEXPOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check IFGLEXPOR.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SHREDIGCEM.BO has a market cap of 10.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SHREDIGCEM.BO trades at ₹70.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SHREDIGCEM.BO's P/E ratio is 30.23. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SHREDIGCEM.BO's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SHREDIGCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SHREDIGCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SHREDIGCEM.NS has a market cap of 10.6B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SHREDIGCEM.NS trades at ₹71.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SHREDIGCEM.NS's P/E ratio is 29.97. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SHREDIGCEM.NS's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SHREDIGCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SHREDIGCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, DECCANCE.NS has a market cap of 10B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while DECCANCE.NS trades at ₹754.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas DECCANCE.NS's P/E ratio is 30.05. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to DECCANCE.NS's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is less volatile compared to DECCANCE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check DECCANCE.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, DECCANCE.BO has a market cap of 9.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while DECCANCE.BO trades at ₹752.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas DECCANCE.BO's P/E ratio is 29.77. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to DECCANCE.BO's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is less volatile compared to DECCANCE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check DECCANCE.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, APOLLOPIPES.BO has a market cap of 9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while APOLLOPIPES.BO trades at ₹686.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas APOLLOPIPES.BO's P/E ratio is 46.89. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to APOLLOPIPES.BO's ROE of +0.02%. Regarding short-term risk, ELEMARB.BO is more volatile compared to APOLLOPIPES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check APOLLOPIPES.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ORIRAIL.BO has a market cap of 8.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ORIRAIL.BO trades at ₹131.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ORIRAIL.BO's P/E ratio is 23.71. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ORIRAIL.BO's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is less volatile compared to ORIRAIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check ORIRAIL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NCLIND.NS has a market cap of 8.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NCLIND.NS trades at ₹185.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NCLIND.NS's P/E ratio is 16.76. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NCLIND.NS's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to NCLIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check NCLIND.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NCLIND.BO has a market cap of 8.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NCLIND.BO trades at ₹184.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NCLIND.BO's P/E ratio is 16.65. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NCLIND.BO's ROE of +0.07%. Regarding short-term risk, ELEMARB.BO is more volatile compared to NCLIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check NCLIND.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SAURASHCEM.NS has a market cap of 7.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SAURASHCEM.NS trades at ₹68.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SAURASHCEM.NS's P/E ratio is 25.45. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SAURASHCEM.NS's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is less volatile compared to SAURASHCEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check SAURASHCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SAURASHCEM.BO has a market cap of 7.2B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SAURASHCEM.BO trades at ₹68.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SAURASHCEM.BO's P/E ratio is 25.31. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SAURASHCEM.BO's ROE of +0.03%. Regarding short-term risk, ELEMARB.BO is less volatile compared to SAURASHCEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check SAURASHCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SHIVACEM.BO has a market cap of 5.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SHIVACEM.BO trades at ₹18.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SHIVACEM.BO's P/E ratio is -3.69. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SHIVACEM.BO's ROE of -1.37%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SHIVACEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SHIVACEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ACL.NS has a market cap of 5.1B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ACL.NS trades at ₹55.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ACL.NS's P/E ratio is -3.08. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ACL.NS's ROE of -1.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ACL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ACL.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ACL.BO has a market cap of 5.1B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ACL.BO trades at ₹55.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ACL.BO's P/E ratio is -3.06. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ACL.BO's ROE of -1.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ACL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ACL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, APCL.BO has a market cap of 3.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while APCL.BO trades at ₹127.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas APCL.BO's P/E ratio is -9.22. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to APCL.BO's ROE of -0.18%. Regarding short-term risk, ELEMARB.BO is less volatile compared to APCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check APCL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GSLSU.BO has a market cap of 3.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GSLSU.BO trades at ₹85.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GSLSU.BO's P/E ratio is -20.51. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GSLSU.BO's ROE of -0.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to GSLSU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check GSLSU.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, APCL.NS has a market cap of 3.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while APCL.NS trades at ₹127.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas APCL.NS's P/E ratio is -9.02. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to APCL.NS's ROE of -0.18%. Regarding short-term risk, ELEMARB.BO is less volatile compared to APCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check APCL.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GSLSU.NS has a market cap of 3.8B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GSLSU.NS trades at ₹85.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GSLSU.NS's P/E ratio is -20.23. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GSLSU.NS's ROE of -0.06%. Regarding short-term risk, ELEMARB.BO is less volatile compared to GSLSU.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check GSLSU.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ZODIAC.BO has a market cap of 3.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ZODIAC.BO trades at ₹246.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ZODIAC.BO's P/E ratio is -58.53. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ZODIAC.BO's ROE of +0.21%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ZODIAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ZODIAC.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ZODIAC.NS has a market cap of 3.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ZODIAC.NS trades at ₹243.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ZODIAC.NS's P/E ratio is 65.91. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ZODIAC.NS's ROE of +0.21%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ZODIAC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ZODIAC.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NAVKAR.BO has a market cap of 3.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NAVKAR.BO trades at ₹14.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NAVKAR.BO's P/E ratio is 145.10. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NAVKAR.BO's ROE of -0.01%. Regarding short-term risk, ELEMARB.BO is less volatile compared to NAVKAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check NAVKAR.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GSCLCEMENT.NS has a market cap of 3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GSCLCEMENT.NS trades at ₹33.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GSCLCEMENT.NS's P/E ratio is -87.37. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GSCLCEMENT.NS's ROE of +0.04%. Regarding short-term risk, ELEMARB.BO is more volatile compared to GSCLCEMENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check GSCLCEMENT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KESORAMIND.NS has a market cap of 2.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KESORAMIND.NS trades at ₹8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KESORAMIND.NS's P/E ratio is -1.94. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KESORAMIND.NS's ROE of +18.55%. Regarding short-term risk, ELEMARB.BO is more volatile compared to KESORAMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check KESORAMIND.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SAHYADRI.NS has a market cap of 2.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SAHYADRI.NS trades at ₹250.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SAHYADRI.NS's P/E ratio is 12.05. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SAHYADRI.NS's ROE of +0.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to SAHYADRI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check SAHYADRI.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KESORAMIND.BO has a market cap of 2.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KESORAMIND.BO trades at ₹8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KESORAMIND.BO's P/E ratio is -1.93. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KESORAMIND.BO's ROE of +18.55%. Regarding short-term risk, ELEMARB.BO is less volatile compared to KESORAMIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check KESORAMIND.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, SKCIL.BO has a market cap of 2.7B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while SKCIL.BO trades at ₹152.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas SKCIL.BO's P/E ratio is 7735.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to SKCIL.BO's ROE of -0.01%. Regarding short-term risk, ELEMARB.BO is less volatile compared to SKCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check SKCIL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ASIIL.BO has a market cap of 2.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ASIIL.BO trades at ₹26.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ASIIL.BO's P/E ratio is 9.31. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ASIIL.BO's ROE of +0.08%. Regarding short-term risk, ELEMARB.BO is more volatile compared to ASIIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check ASIIL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, GLITTEKG.BO has a market cap of 1.9B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while GLITTEKG.BO trades at ₹76.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas GLITTEKG.BO's P/E ratio is 8.51. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to GLITTEKG.BO's ROE of +4.29%. Regarding short-term risk, ELEMARB.BO is less volatile compared to GLITTEKG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check GLITTEKG.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BRPL.BO has a market cap of 1.6B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BRPL.BO trades at ₹119.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BRPL.BO's P/E ratio is 17.68. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BRPL.BO's ROE of +0.27%. Regarding short-term risk, ELEMARB.BO is more volatile compared to BRPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check BRPL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NAVKARURB.BO has a market cap of 1.5B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NAVKARURB.BO trades at ₹1.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NAVKARURB.BO's P/E ratio is -15.22. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NAVKARURB.BO's ROE of -0.01%. Regarding short-term risk, ELEMARB.BO is less volatile compared to NAVKARURB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check NAVKARURB.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NAVKARURB.NS has a market cap of 1.5B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NAVKARURB.NS trades at ₹1.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NAVKARURB.NS's P/E ratio is -15.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NAVKARURB.NS's ROE of +0.00%. Regarding short-term risk, ELEMARB.BO is less volatile compared to NAVKARURB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check NAVKARURB.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KEIL.BO has a market cap of 1.4B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KEIL.BO trades at ₹15.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KEIL.BO's P/E ratio is -1648.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KEIL.BO's ROE of -0.00%. Regarding short-term risk, ELEMARB.BO is less volatile compared to KEIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check KEIL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, TRL.BO has a market cap of 1.3B. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while TRL.BO trades at ₹108.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas TRL.BO's P/E ratio is 51.11. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to TRL.BO's ROE of +0.06%. Regarding short-term risk, ELEMARB.BO is less volatile compared to TRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check TRL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, RISHILASE.BO has a market cap of 992.3M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while RISHILASE.BO trades at ₹108.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas RISHILASE.BO's P/E ratio is 11.76. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to RISHILASE.BO's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is less volatile compared to RISHILASE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check RISHILASE.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, PANCM.BO has a market cap of 987M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while PANCM.BO trades at ₹134.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas PANCM.BO's P/E ratio is -1.10. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to PANCM.BO's ROE of +0.41%. Regarding short-term risk, ELEMARB.BO is less volatile compared to PANCM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check PANCM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BVCL.BO has a market cap of 934.5M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BVCL.BO trades at ₹42.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BVCL.BO's P/E ratio is 4217.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BVCL.BO's ROE of +0.00%. Regarding short-term risk, ELEMARB.BO is more volatile compared to BVCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check BVCL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BVCL.NS has a market cap of 931.6M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BVCL.NS trades at ₹42.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BVCL.NS's P/E ratio is 4204.00. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BVCL.NS's ROE of +0.00%. Regarding short-term risk, ELEMARB.BO is more volatile compared to BVCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check BVCL.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, PACIFICI.BO has a market cap of 928.8M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while PACIFICI.BO trades at ₹134.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas PACIFICI.BO's P/E ratio is 23.60. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to PACIFICI.BO's ROE of +0.01%. Regarding short-term risk, ELEMARB.BO is more volatile compared to PACIFICI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check PACIFICI.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KAKATCEM.BO has a market cap of 897.9M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KAKATCEM.BO trades at ₹113.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KAKATCEM.BO's P/E ratio is -3.30. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KAKATCEM.BO's ROE of -0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to KAKATCEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check KAKATCEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KAKATCEM.NS has a market cap of 892.1M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KAKATCEM.NS trades at ₹114.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KAKATCEM.NS's P/E ratio is -3.25. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KAKATCEM.NS's ROE of -0.13%. Regarding short-term risk, ELEMARB.BO is more volatile compared to KAKATCEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check KAKATCEM.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, CEETAIN.BO has a market cap of 691.8M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while CEETAIN.BO trades at ₹44.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas CEETAIN.BO's P/E ratio is 207.39. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to CEETAIN.BO's ROE of +0.01%. Regarding short-term risk, ELEMARB.BO is less volatile compared to CEETAIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check CEETAIN.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, NILACHAL.BO has a market cap of 683.3M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while NILACHAL.BO trades at ₹33.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas NILACHAL.BO's P/E ratio is -2.81. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to NILACHAL.BO's ROE of +1.06%. Regarding short-term risk, ELEMARB.BO is more volatile compared to NILACHAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check NILACHAL.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, AHMDSTE.BO has a market cap of 672.9M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while AHMDSTE.BO trades at ₹165.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas AHMDSTE.BO's P/E ratio is 7.07. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to AHMDSTE.BO's ROE of +0.22%. Regarding short-term risk, ELEMARB.BO is less volatile compared to AHMDSTE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check AHMDSTE.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, RESTILE.BO has a market cap of 636.8M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while RESTILE.BO trades at ₹6.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas RESTILE.BO's P/E ratio is -92.57. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to RESTILE.BO's ROE of +0.00%. Regarding short-term risk, ELEMARB.BO is more volatile compared to RESTILE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check RESTILE.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BURNPUR.NS has a market cap of 568.4M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BURNPUR.NS trades at ₹33.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BURNPUR.NS's P/E ratio is -0.21. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BURNPUR.NS's ROE of +0.10%. Regarding short-term risk, ELEMARB.BO is less volatile compared to BURNPUR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check BURNPUR.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, BHEEMACEM.BO has a market cap of 526.7M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while BHEEMACEM.BO trades at ₹16.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas BHEEMACEM.BO's P/E ratio is -1.56. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to BHEEMACEM.BO's ROE of -5.24%. Regarding short-term risk, ELEMARB.BO is less volatile compared to BHEEMACEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check BHEEMACEM.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, DIVSHKT.BO has a market cap of 513M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while DIVSHKT.BO trades at ₹48.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas DIVSHKT.BO's P/E ratio is 35.43. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to DIVSHKT.BO's ROE of +0.01%. Regarding short-term risk, ELEMARB.BO is more volatile compared to DIVSHKT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ELEMARB.BO.Check DIVSHKT.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, PRATIK.BO has a market cap of 463.9M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while PRATIK.BO trades at ₹7.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas PRATIK.BO's P/E ratio is 55.85. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to PRATIK.BO's ROE of +0.23%. Regarding short-term risk, ELEMARB.BO is less volatile compared to PRATIK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check PRATIK.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ANDHRACEMT.NS has a market cap of 456.2M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ANDHRACEMT.NS trades at ₹4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ANDHRACEMT.NS's P/E ratio is -0.03. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ANDHRACEMT.NS's ROE of -0.20%. Regarding short-term risk, ELEMARB.BO is less volatile compared to ANDHRACEMT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check ANDHRACEMT.NS's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, ZWELCAST.BO has a market cap of 443.7M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while ZWELCAST.BO trades at ₹707.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas ZWELCAST.BO's P/E ratio is -0.07. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to ZWELCAST.BO's ROE of -0.17%. Regarding short-term risk, ELEMARB.BO is less volatile compared to ZWELCAST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check ZWELCAST.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, KEERTHI.BO has a market cap of 432.9M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while KEERTHI.BO trades at ₹55.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas KEERTHI.BO's P/E ratio is -2.26. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to KEERTHI.BO's ROE of -0.42%. Regarding short-term risk, ELEMARB.BO is less volatile compared to KEERTHI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check KEERTHI.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, MAYUKH.BO has a market cap of 432M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while MAYUKH.BO trades at ₹2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas MAYUKH.BO's P/E ratio is 56.25. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to MAYUKH.BO's ROE of +0.12%. Regarding short-term risk, ELEMARB.BO is less volatile compared to MAYUKH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check MAYUKH.BO's competition here

ELEMARB.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ELEMARB.BO stands at 739.3M. In comparison, RALEGRA.BO has a market cap of 429.4M. Regarding current trading prices, ELEMARB.BO is priced at ₹195.00, while RALEGRA.BO trades at ₹40.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ELEMARB.BO currently has a P/E ratio of 19.78, whereas RALEGRA.BO's P/E ratio is N/A. In terms of profitability, ELEMARB.BO's ROE is +0.02%, compared to RALEGRA.BO's ROE of N/A. Regarding short-term risk, ELEMARB.BO is less volatile compared to RALEGRA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ELEMARB.BO.Check RALEGRA.BO's competition here